Delivery of the Gentamicin to the Eye via Iontophoresis
Raiskup-Wolf F.1, Eljarrat-Binstock E.2, Rehák M.3, Domb A.2, Frucht-Pery J.4
1Očná klinika, Fakultná nemocnica Univerzity Lipsko, Nemecko, prednosta prof. Dr. med. Peter Wiedemann 2Oddelenie Lekárskej Chémie a Prírodných Výrobkov, Lekárska Fakulta, Hebrejská univerzita, Jeruzalem, Izrael, prednosta prof. Avi Domb, PhD. 3Oční klinika LF UP a FN, Olomouc, prednosta doc. MUDr. Jiří Řehák, CSc. 4Očná klinika, Fakultná nemocnica Hadassah, Jeruzalem, Izrael, prednosta prof. Jacob Pe`er, M.D. |
|
Summary:
The aim of this study was to evaluate the use of solid hydrogel as a probe for
the drug delivery to the rabbit eye upon application of low current
iontophoresis. Hydroxyethyl methacrylate (HEMA), cross-linked with ethylenglycol dimethacrylate (EGDMA) were prepared to form solid hydrogels.
The concentrations of gentamicin sulfate in different segments of rabbit eye
after transconjunctival and transscleral iontophoresis were also studied. For
iontophoresis we used a portable Mini Ion device (designed at Hebrew
University of Jerusalem) and applied a current from 0 mA to 1.5 mA for pre-set
period from 30 to 120 seconds and after application the concentrations of
gentamicin in cornea were assayed. The rabbits in control group were treated
with fortified gentamicin eye-drops (concentration 1.4 %). The highest
concentration of gentamicin sulfate was reached after iontophoresis with
current intensity of 1.5 mA applied for 60 s. High gentamicin concentration
were found in the retina and in the sclera four hours after transscleral
iontophoresis, the lowest concentration was obtained in vitreous.
The delivery of gentamicin to the eye via iontophoresis with solid
HEMA/EGDMA hydrogels seems to be promising method achieving high
concentrations of the drug in the eye tissue.
Key words:
iontophoresis, hydrogel, gentamicin sulfate, hydroxyethyl
methacrylate, corneal concentration of the drug
|